Form 13-F position report

ROYALTY PHARMA PLC

Reported by CM Management LLC

RPRX CUSIP G7709Q104 Manager CIK 0001841857

Reported 125,000 shares, unchanged from the prior quarter.

Reported value 4.1%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 4.89% This manager · Q3 2026
Shares 125,000 Quarter-end amount reported
Reported value $7,295,000 Fair value at quarter end
Consecutive quarters held 5 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-12-31 3511250
2024-03-31 4859200
2024-06-30 4219200
2024-09-30 4526400
2024-12-31 4081600
2025-03-31 0
2025-09-30 1764000
2025-12-31 2898000
2026-03-31 5996250
2026-06-30 7008750
2026-09-30 7295000

Quarterly position history

How this manager's reported quarter-end position changed over time.

11 quarters
Quarterly reported position history for ROYALTY PHARMA PLC held by CM Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 125,000 0 (0.0%) 4.89% $7,295,000 2026-11-12
Q2 2026 Unchanged 125,000 0 (0.0%) 4.45% $7,008,750 2026-08-13
Q1 2026 Added 125,000 +50,000 (66.7%) 5.01% $5,996,250 2026-05-08
Q4 2025 Added 75,000 +25,000 (50.0%) 2.44% $2,898,000 2026-02-02
Q3 2025 New 50,000 +50,000 (0.0%) 1.47% $1,764,000 2025-11-13
Q1 2025 Reduced 0 -160,000 (-100.0%) 0 $0 2025-05-09
Q4 2024 Unchanged 160,000 0 (0.0%) 3.65% $4,081,600 2025-02-07
Q3 2024 Unchanged 160,000 0 (0.0%) 3.61% $4,526,400 2024-11-12
Q2 2024 Unchanged 160,000 0 (0.0%) 3.87% $4,219,200 2024-08-01
Q1 2024 Added 160,000 +35,000 (28.0%) 4.08% $4,859,200 2024-05-14
Q4 2023 New 125,000 +125,000 (0.0%) 2.82% $3,511,250 2024-02-12

Who else reported the position

752 managers reported ROYALTY PHARMA PLC for Q3 2026.

Managers reporting ROYALTY PHARMA PLC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
MORGAN STANLEY Reduced 41,100,185 -1,831,412 0.12% $2,398,606,956 26 qtrs
Capital International Investors Reduced 33,897,019 -1,376,751 0.41% $1,978,230,029 6 qtrs
BlackRock Inc Added 29,117,396 +1,284,419 0.03% $1,699,291,230 9 qtrs
FMR LLC Reduced 19,348,880 -5,164,934 0.05% $1,129,200,661 26 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 14,712,137 +3,518,480 0.09% $858,601,000 26 qtrs
STATE STREET CORPORATION Added 12,951,600 +613,371 0.02% $755,855,376 26 qtrs
Swedbank AB Reduced 10,260,593 -466,015 0.51% $598,808,207 22 qtrs
BAILLIE GIFFORD & CO Reduced 9,151,948 -863,630 0.5% $534,107,685 19 qtrs
Capital World Investors Reduced 8,755,768 -761,569 0.06% $510,986,620 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 8,546,758 +488,710 0.03% $497,512,565 26 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 12, 2026
Filing type
13F-HR
Position type
COM - CLASS A

Voting authority reported

Sole
125,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.